Cipla’s South Africa-based subsidiary Cipla Medpro has announced its collaboration with Teva Pharmaceuticals Industries, the world’s largest generic pharmaceutical company.
Restricted to the territory of South Africa, the collaboration is a sales and distribution arrangement whereby Cipla Medpro will exclusively market Teva’s broad pharmaceutical product portfolio, Cipla said in a filing to the BSE.
The focus areas are oncology, the central nervous system, women’s health, cardiovascular and ophthalmology, amongst other speciality products.
The collaboration is subject to the approval of the Competition Commission of South Africa.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.